Clinical Trials Browser

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Adenoviridae Infections, Urinary Bladder Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Carcinoma, Transitional Cell

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

Neoplasms, Urologic Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Prostatic Neoplasms

Prostatic Neoplasms, Urinary Incontinence

Kidney Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell

Carcinoma, Renal Cell, Kidney Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms

Brain Neoplasms, Carcinoma, Renal Cell

Prostatic Neoplasms

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Carcinoma, Renal Cell

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Urinary Bladder Neoplasms, Ureteral Neoplasms

Carcinoma, Renal Cell

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Clinical Trials

HARMONY

exBOND

Superman

N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer

BOOST

RESCUE

PuraBond

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Patient Recall of Cancer Screening and Diagnosis

PROTOMEN

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

NeoPSMA

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)

HARRIER

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology

REPRESENTATION

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

CHEMOPROST

Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity

PSMA Therapy and Immunotherapy in Kidney Cancer

Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases

TALON

AVENTURINE

iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

HRPCa-II

A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

KATANA E3M

KATANA E6M

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer